Iron-oxide doxorubicin nanoparticles (Dox-Nps) were applied to improve anticancer drug delivery.
Cytotoxicity of Dox-Nps was two/three times higher than free Dox, whereas Nps alone were not cytotoxic against HT29 cells.
Dox-Nps were observed to penetrate cancer cells with higher efficacy than free Dox.
The treatment of HT-29 cells with Dox-Nps and Dox at IC50 resulted in G2/M arrest followed by apoptosis and necrosis.